|
|
Volumn 40, Issue 5-6, 2001, Pages 625-630
|
|
Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia
a
a
a
a
a
a
a
a
|
|
Author keywords
Adhesion molecules; Adhesive immunophenotype; B lineage childhood acute lymphoblastic leukemia; Hybrid acute leukemia
|
|
Indexed keywords
ANTILEUKEMIC AGENT;
BETA1 INTEGRIN;
CD11B ANTIGEN;
CD18 ANTIGEN;
CD19 ANTIGEN;
CD2 ANTIGEN;
CD24 ANTIGEN;
CD3 ANTIGEN;
CD33 ANTIGEN;
CD44V ANTIGEN;
CD47 ANTIGEN;
CD56 ANTIGEN;
CD7 ANTIGEN;
CELL ADHESION MOLECULE;
COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;
DNA NUCLEOTIDYLEXOTRANSFERASE;
GLYCOPROTEIN P 15095;
HERMES ANTIGEN;
HLA DR ANTIGEN;
INTERCELLULAR ADHESION MOLECULE 1;
L SELECTIN;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;
LYMPHOCYTE RECEPTOR;
MICROSOMAL AMINOPEPTIDASE;
PADGEM PROTEIN;
PREDNISONE;
SCLEROPROTEIN;
UNINDEXED DRUG;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ALPHA CHAIN;
ANTIGEN EXPRESSION;
ARTICLE;
B LYMPHOCYTE;
BETA CHAIN;
CANCER CELL;
CANCER RECURRENCE;
CANCER RISK;
CELL HETEROGENEITY;
CENTRAL NERVOUS SYSTEM;
CHILD;
CHILDHOOD LEUKEMIA;
CHROMOSOME ABERRATION;
CLINICAL FEATURE;
CONTROLLED STUDY;
CORRELATION FUNCTION;
DIAGNOSTIC TEST;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN CELL;
IMMUNOPHENOTYPING;
LEUKEMIA CELL LINE;
LEUKOCYTE COUNT;
LYMPHOBLAST;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN ANALYSIS;
PROTEIN EXPRESSION;
PROTEIN FAMILY;
RISK ASSESSMENT;
SPLENOMEGALY;
TREATMENT OUTCOME;
|
|
EID: 0035049303
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.3109/10428190109097660 Document Type: Article |
|
Times cited : (27)
|
|
References (16)
|
